| __timestamp | Ionis Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 9216000000 |
| Thursday, January 1, 2015 | 322292000 | 8296000000 |
| Friday, January 1, 2016 | 344320000 | 10044000000 |
| Sunday, January 1, 2017 | 374644000 | 11560000000 |
| Monday, January 1, 2018 | 1820000 | 10558000000 |
| Tuesday, January 1, 2019 | 4000000 | 9351000000 |
| Wednesday, January 1, 2020 | 12000000 | 8933000000 |
| Friday, January 1, 2021 | 11000000 | 8284000000 |
| Saturday, January 1, 2022 | 14000000 | 7952000000 |
| Sunday, January 1, 2023 | 9133000 | 8200000000 |
| Monday, January 1, 2024 | 11215000 | 8480000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Teva Pharmaceutical Industries Limited and Ionis Pharmaceuticals, Inc. have shown contrasting trends in their cost of revenue from 2014 to 2023. Teva, a global leader, saw its cost of revenue peak in 2017 at approximately $11.56 billion, before gradually declining to around $8.2 billion by 2023. This represents a 29% decrease over six years, reflecting strategic cost management and market adjustments.
Conversely, Ionis Pharmaceuticals, a pioneer in RNA-targeted therapeutics, experienced a more volatile trajectory. Starting at $241 million in 2014, their costs surged to $374 million by 2017, only to plummet to $9 million in 2023. This dramatic 97% reduction highlights Ionis's shift towards more efficient operations and possibly a strategic pivot in their business model. These trends underscore the dynamic nature of the pharmaceutical sector, where adaptability is key.
AbbVie Inc. vs Teva Pharmaceutical Industries Limited: Efficiency in Cost of Revenue Explored
AstraZeneca PLC vs Teva Pharmaceutical Industries Limited: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited's Expenses
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Intra-Cellular Therapies, Inc.'s Expenses
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs HUTCHMED (China) Limited
Comparing Cost of Revenue Efficiency: Bio-Techne Corporation vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Ionis Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Corcept Therapeutics Incorporated vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Ionis Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down Ionis Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored